It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2016.
2016 | Kolkata, West Bengal, India | Struck OffAtcas Pharmaceutical Private Limited, a struck off private limited company, was established on 16 November 2016 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U74999WB2016PTC218310. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.
Its leadership includes Subhra Das (Director), Aftabuddin Shaikhmahammad Sircar (Director), Amitabha Chaudhuri (Director). Past directors included Tanmoy Kumar Das. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Shantinikatan Apartment Gr. Floor Phase I Block C, Kolkata, West Bengal, 700135.
U74999WB2016PTC218310
218310
16 November 2016
₹1.00 M
₹0.60 M
Roc Kolkata
Unlisted
Struck Off
Explore comprehensive insights into Atcas Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhra Das | Director | 16 Nov 2016 | Current |
| Aftabuddin Shaikhmahammad Sircar | Director | 16 Nov 2016 | Current |
| Amitabha Chaudhuri | Director | 16 Nov 2016 | Current |
| Chandan Singha Roy | Director | 16 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Atcas Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Atcas Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Atcas Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Atcas Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atcas Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Atcas Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
Progress on Atcas Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kolkata. was documented.
The activity Subhra Das was appointed as a Director was appointed as a Director on 16 Nov 2016 & has been associated with this company since 9 years 18 days . was completed.
Progress on Aftabuddin Shaikhmahammad Sircar was appointed as a Director was appointed as a Director on 16 Nov 2016 & has been associated with this company since 9 years 18 days . was documented.
The activity Amitabha Chaudhuri was appointed as a Director was appointed as a Director on 16 Nov 2016 & has been associated with this company since 9 years 18 days . was completed.
The activity Chandan Singha Roy was appointed as a Director was appointed as a Director on 16 Nov 2016 & has been associated with this company since 9 years 18 days . was completed.
The CIN of Atcas Pharmaceutical Private Limited is U74999WB2016PTC218310.
Atcas Pharmaceutical Private Limited is headquartered at Shantinikatan Apartment Gr. Floor Phase I Block C, Kolkata, West Bengal, 700135.
Atcas Pharmaceutical Private Limited was incorporated on 16 November 2016.
The current directors of Atcas Pharmaceutical Private Limited are
The primary industry of Atcas Pharmaceutical Private Limited is Manufacturing.
Atcas Pharmaceutical Private Limited is unlisted.
The authorized capital of Atcas Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX